NY-COTY
20.4.2020 20:43:06 CEST | Business Wire | Press release
Coty Inc. announced today that Calvin Klein fragrances has achieved a Material Health Certificate at the Silver level from the Cradle to Cradle Products Innovation Institute for Calvin Klein’s first clean and environmentally conscious fragrance, CK EVERYONE Eau de toilette.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200420005792/en/
Silver level material health certification indicates that 100% of the chemical substances in CK EVERYONE Eau de toilette have been assessed and are compliant with the Cradle to Cradle Certified Product Standard material health requirements at the Silver level. These achievements also serve as the foundation of a material health optimization strategy for further improving the environmental safety of the fragrance over time.
Simona Cattaneo, President of Luxury Brands at Coty, said: “We are proud of Coty’s first Cradle to Cradle Material Health certificate for CK EVERYONE Eau de toilette which demonstrates the positive impact of our Beauty That Lasts platform. The Material Health certificate reinforces Coty’s commitment to its sustainability platform, with the objective of building a better business while making a positive contribution towards societal, ethical and environmental change within the beauty industry.”
The Cradle to Cradle Certified™ Material Health Certificate offers a solution to growing industry and consumer interest in knowing more about the chemicals used in products across their supply chains and avoiding chemicals of concern. By using the rigorous, globally recognized material health assessment methodology of the Cradle to Cradle Certified Product Standard, the Material Health Certificate provides manufacturers with a trusted means of assessing, optimizing and verifying their product chemistries for safety and the environment. The material health evaluation of CK EVERYONE Eau de toilette was executed by MBDC, a third-party Cradle to Cradle accredited assessor.
“Achieving a Cradle to Cradle Material Health certificate for CK EVERYONE Eau de toilette is another positive step in moving the beauty industry towards the universal use of materials that are safe, circular and responsible,” said Dr. Christina Raab, Vice President of Strategy and Development for the Institute. “We look forward to Coty’s continued leadership as the company uses the Cradle to Cradle Certified Product Standard as a framework for improving the sustainability of this and other products.”
“We are thrilled to collaborate with Coty on their first Material Health Certificate for CK EVERYONE Eau de toilette,” said Jay Bolus, President of MBDC. “By obtaining a Material Health Certificate, they are communicating their commitment to transparency and that their fragrance is made with healthier materials. Coty is raising the bar for the beauty industry by insisting on product quality based on Cradle to Cradle Design™.”
About the Cradle to Cradle Products Innovation Institute
The Cradle to Cradle Products Innovation Institute is dedicated to powering innovation for the circular economy through products that have a positive impact on people and planet. Through the Cradle to Cradle Certified™ Products Program, the Institute sets the global standard for products that are safe, circular and made responsibly. Cradle to Cradle Certified is used by future-focused designers, brands, retailers and manufacturers across the value chain to innovate and optimize materials and products according to the world’s most advanced science-based measures for material health, product circularity, renewable energy and climate, water and soil stewardship, and social fairness.
The Institute also powers the global shift to a circular economy through partnerships and collaborative initiatives that equip businesses, governments and other stakeholders with the technical solutions and knowledge they need to innovate the way products are designed and made.
The Institute is headquartered in Oakland, California and Amsterdam, the Netherlands with offices in Washington DC. For more information, follow @c2ccertified or visit c2ccertified.org.
About MBDC
MBDC is a firm founded in 1995 by world-renowned architect William McDonough and chemist Dr. Michael Braungart. MBDC originated the Cradle to Cradle Design™ framework and the Cradle to Cradle Certified™ Products Program. MBDC leads companies to create a world of good by assessing product designs and integrating the framework into corporate strategy, communications, operations, and supply chains. Using the process of inventory, assessment and optimization, MBDC provides unique technical expertise to develop sustainable circular economy solutions around material health, material reutilization, renewable energy use, water stewardship and social fairness. MBDC partners with clients to provide scientific assessments and spur design innovation to create a world of good.
For additional information about MBDC, please visit www.mbdc.com
About CK EVERYONE
CK EVERYONE Eau de toilette is a clean and environmentally conscious fragrance, formulated with naturally derived ingredients, naturally derived alcohol, is vegan, recyclable, and is packaged with recycled materials.
CK EVERYONE Eau de toilette is a citrus fragrance that uplifts with zesty organic orange oil, a blue tea accord, and a vibrant cedarwood base creating the perfect combination of clean freshness, sweet sensuality and provocative edge. Master perfumer and creator of the original CK ONE fragrance, Alberto Morillas crafted the clean and genderless fragrance exuding freshness using 77% of naturally derived ingredients.
The CK EVERYONE bottle and packaging were created from recycled materials to honor its purity and simplicity. The ultra-modern transparent glass bottle contains 10% of post-consumer recycled materials and is recyclable with the removal of the pump and the elastic while the folding carton contains 30% of post-consumer recycled materials.
CK EVERYONE is available globally in a 50ml, 100ml, and 200ml, Eau de toilette spray.
About Coty Inc.
Coty is one of the world’s largest beauty companies with an iconic portfolio of brands across fragrance, color cosmetics, hair color and styling, and skin and body care. Coty is the global leader in fragrance, a strong number two in professional hair color & styling, and number three in color cosmetics. Coty’s products are sold in over 150 countries around the world. Coty and its brands are committed to a range of social causes as well as seeking to minimize its impact on the environment.
For additional information about Coty Inc., please visit www.Coty.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20200420005792/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SINOVAC Regained Compliance With the Nasdaq Global Market’s Listing Requirements15.6.2026 12:00:00 CEST | Press release
Sinovac Biotech Ltd. (Nasdaq: SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated June 10, 2026 (the "Notification Letter"), from Hearing Advisor of The Nasdaq Stock Market LLC., indicating that the Company has regained compliance with Listing Rule 5250(c)(1) and that the Company is therefore in compliance with the Nasdaq Global Market's listing requirements. As noted in the Hearing Panel's May 20, 2026 compliance determination, the Company remains under a Mandatory Panel Monitor pursuant to Listing Rule 5815(d)(4)(B) until May 20, 2027. The Company filed its annual report on Form 20-F for the year ended December 31, 2025 on June 5, 2026. The Notification Letter also stated that the hearing before the Hearings Panel, applied for by the Company, had accordingly been canceled. About SINOVAC Sinovac Biotech Ltd. (SINOVAC) is a China-based global biopharmaceutical company, with a mission
KRM22 partners with Sigma AI to enhance market surveillance and risk intelligence capabilities15.6.2026 12:00:00 CEST | Press release
KRM22, the technology and software investment company focused on risk management solutions for capital markets, today announced a strategic partnership with Sigma AI, a leading provider of AI-driven financial insights, to integrate advanced news sentiment analytics into its risk management application suite. The integration marks a significant enhancement to KRM22’s capabilities, enabling clients to incorporate real-time market sentiment insights derived from global news sources directly into their risk frameworks. By leveraging Sigma AI’s proprietary natural language processing and machine learning models, KRM22 will help firms better identify emerging risks, anticipate market-moving events, and make more informed trading and compliance decisions. Advancing risk management through AI-driven sentiment analysis As part of the first phase of the collaboration, KRM22 will embed Sigma AI’s news sentiment engine within its application suite. This will provide users with actionable intellige
HUI (HUI:VSE) Merges Traditional and Crypto Finance: Commences Continuous Trading in Vienna With Leading Market Maker and Announces Impending Token Listing on Major Global Exchange15.6.2026 11:15:00 CEST | Press release
The first SaaS SuperApp for startups and VCs capitalizes on a $25M round a from Nimbus Capital and a +15% stock surge, unveiling a v3/v4 roadmap that bridges public equity with digital asset liquidity. HUI S.p.A., the pioneering vertical SuperApp and SaaS company dedicated to the global Venture Capital and startup ecosystem listed on the Vienna Stock Exchange, today released its global product strategy, marking an unprecedented convergence between traditional regulated markets and decentralized finance. Driven by a +15% stock surge and the consolidation of its $25 million round a equity commitment fully subscribed by global institutional fund Nimbus Capital, the company announced its upcoming transition to continuous trading on the Vienna market in partnership with a leading European market maker, alongside the activation of the initial PUT options tied to the round. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/2026061293689
Syngenta Signs MoU to Be Strategic Partner in India’s First Open-Data Agricultural Ecosystem Annam.AI15.6.2026 09:35:00 CEST | Press release
Agricultural innovation leader to contribute with agronomic expertise in building accurate crop health, pest forecasting and heat stress models India’s agriculture sector is a global powerhouse, uniquely characterized by its massive scale, vast arable land, diverse agro-climatic zones and rich biodiversity. These strengths have propelled the country to become one of the world’s leading producers of crops such as rice and wheat. However, farmers in the country face significant challenges – from erratic monsoons, severe droughts and unseasonal rains compounded by El Nino, to pests and diseases that destroy an estimated 30 percent of crops annually. More than 80 percent of India’s estimated 150 million farming households are composed of smallholder farmers who operate on less than two hectares of land. This limits economies of scale, sets obstacles to the wider adoption of advanced technologies and could widen a systemic gap between large commercial agricultural operations and the bulk of
Pelago Bioscience Acquires RG Discovery, Forming an Integrated Drug Discovery Partner Spanning Biology and Chemistry15.6.2026 09:00:00 CEST | Press release
The combination unites Pelago Bioscience’s industry-leading and proprietary cellular target engagement capabilities with RG Discovery’s deep medicinal chemistry and custom synthesis expertise - enabling customers to advance drug discovery programs across the full design-make-test-analyze-(DMTA) cycle with a single specialist partner. Pelago Bioscience, a specialist drug discovery focused contract research organization (CRO), known for its industry-leading cell-based target engagement assays, is pleased to announce the acquisition of RG Discovery, and thereby adding deep expertise in medicinal chemistry, custom synthesis, and integrated drug discovery. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260615340933/en/ Michael Dabrowski, Chief Executive Officer of Pelago Bioscience By combining Pelago Bioscience's biology-focused capabilities with RG Discovery's chemistry expertise, the enlarged platform will enable drug discover
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom